Amphastar Pharmaceuticals, Inc. 10-Q filing
Filed 2025-08-07 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001297184-25-000050
- Form type
- 10-Q
- CIK
- 0001297184
- Primary document
- https://www.sec.gov/Archives/edgar/data/1297184/000129718425000050/amph-20250630x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Amphastar Pharmaceuticals, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $344.9M | - | - |
| Cost Of Revenue | $173.2M | - | - |
| Gross Profit | $171.7M | - | - |
| Operating Income | $79.5M | - | - |
| Net Income | $56.3M | - | - |
| Eps Basic | 1.19 | - | - |
| Eps Diluted | 1.15 | - | - |
| Cash And Equivalents | $187.7M | - | - |
| Total Assets | $1.6B | - | - |
| Total Liabilities | $857.9M | - | - |
| Operating Cash Flow | $70.7M | - | - |
| Capital Expenditures | $21.3M | - | - |